1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Molecular Diagnostics Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Molecular Diagnostics Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Development of new products and increase in demand for point-or-care testing
5.2 Market Opportunities
- 5.2.1 Advancement in Molecular Diagnostics Technologies
5.3 Future Trends
- 5.3.1 Molecular Diagnostics in Personalized Medicine
5.4 Impact of Drivers and Restraints
6. Europe Molecular Diagnostics Market Regional Analysis
6.1 Europe Molecular Diagnostics Market Overview
6.2 Europe Molecular Diagnostics Market Revenue 2020-2030 (US$ Million)
6.3 Europe Molecular Diagnostics Market Forecast Analysis
7. Europe Molecular Diagnostics Market Analysis – by Disease Area
7.1 Oncology
- 7.1.1 Overview
- 7.1.2 Oncology: Europe Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Infectious Disease
- 7.2.1 Overview
- 7.2.2 Infectious Disease: Europe Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Genetic Testing
- 7.3.1 Overview
- 7.3.2 Genetic Testing: Europe Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Cardiac Diseases
- 7.4.1 Overview
- 7.4.2 Cardiac Diseases: Europe Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Immune System Disorders
- 7.5.1 Overview
- 7.5.2 Immune System Disorders: Europe Molecular Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Molecular Diagnostics Market Analysis – by Technology
8.1 Polymerase Chain Reaction
- 8.1.1 Overview
- 8.1.2 Polymerase Chain Reaction: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Isothermal Nucleic Acid Amplification Technology
- 8.2.1 Overview
- 8.2.2 Isothermal Nucleic Acid Amplification Technology: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3 DNA Sequencing & Next-Generation Sequencing
- 8.3.1 Overview
- 8.3.2 DNA Sequencing & Next-Generation Sequencing: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 DNA Microarrays
- 8.4.1 Overview
- 8.4.2 DNA Microarrays: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 In-Situ Hybridization
- 8.5.1 Overview
- 8.5.2 In-Situ Hybridization: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Molecular Diagnostics Market Analysis – by Product and Services
9.1 Assays & Kits
- 9.1.1 Overview
- 9.1.2 In-Situ Hybridization: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Instruments
- 9.2.1 Overview
- 9.2.2 In-Situ Hybridization: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Services & Software
- 9.3.1 Overview
- 9.3.2 In-Situ Hybridization: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Molecular Diagnostics Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Molecular Diagnostics Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.1.1.1 Europe Molecular Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 UK: Europe Molecular Diagnostics Market Breakdown, by Disease Area
- 10.1.1.1.2 UK: Europe Molecular Diagnostics Market Breakdown, by Technology
- 10.1.1.1.3 UK: Europe Molecular Diagnostics Market Breakdown, by Product and Services
- 10.1.1.2 Germany:
Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Germany: Europe Molecular Diagnostics Market Breakdown, by Disease Area
- 10.1.1.2.2 Germany: Europe Molecular Diagnostics Market Breakdown, by Technology
- 10.1.1.2.3 Germany: Europe Molecular Diagnostics Market Breakdown, by Product and Services
- 10.1.1.3 France:
Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 France: Europe Molecular Diagnostics Market Breakdown, by Disease Area
- 10.1.1.3.2 France: Europe Molecular Diagnostics Market Breakdown, by Technology
- 10.1.1.3.3 France: Europe Molecular Diagnostics Market Breakdown, by Product and Services
- 10.1.1.4 Russia:
Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.1 Russia: Europe Molecular Diagnostics Market Breakdown, by Disease Area
- 10.1.1.4.2 Russia: Europe Molecular Diagnostics Market Breakdown, by Technology
- 10.1.1.4.3 Russia: Europe Molecular Diagnostics Market Breakdown, by Product and Services
- 10.1.1.5 Italy:
Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.5.1 Italy: Europe Molecular Diagnostics Market Breakdown, by Disease Area
- 10.1.1.5.2 Italy: Europe Molecular Diagnostics Market Breakdown, by Technology
- 10.1.1.5.3 Italy: Europe Molecular Diagnostics Market Breakdown, by Product and Services
- 10.1.1.6 Rest of Europe:
Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Molecular Diagnostics Market Breakdown, by Disease Area
- 10.1.1.6.2 Rest of Europe: Europe Molecular Diagnostics Market Breakdown, by Technology
- 10.1.1.6.3 Rest of Europe: Europe Molecular Diagnostics Market Breakdown, by Product and Services
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Molecular Diagnostics Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Agilent Technologies Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 bioMerieux SA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Danaher
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Illumina Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Novartis AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Qiagen NV
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Siemens Healthineers AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For Europe Molecular Diagnostics Market
